The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
Join patient advocates, drug and device industry leaders, researchers, government partners and investors at this major conference to address together "Shaping the Future Now" for rare diseases and orphan products. Sponsored by NORD and DIA, with major input from FDA and NIH, this event will include general and breakout sessions with three themes: policy, research and regulation, and special challenges.
The 2nd annual U.S. Conference on Rare Diseases and Orphan Products will take place October 22-24 in Washington DC. Everyone is welcome, and the program should be of particular interest to:
- Researchers from academia and drug and device companies
- Patient organizations and those interested in creating one
- Senior managers from drug and device companies interested in rare diseases
- Investors focused on the future of orphan product development
- Policy experts who are concerned about federal or state policies that affect patients with rare diseases
- Providers of services to the rare disease community, including insurance providers and healthcare professionals
- Government officials responsible for rare disease research and orphan product oversight
Register by October 1 for the Early Bird rate. For more information please visit:DIA Rare Diseases 2012
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday. You can also email us at druginfo@fda.hhs.gov.
- For additional drug information, please visit the DDI Web page.
- For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info
- This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA).
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
